ClinicalTrials.gg
RecruitingNCT07850167Updated Sep 30, 2026

Menstrual Cycle, Menopause, and Pain Perception During Endodontic Treatment

An observational study in Pain Perception in Endodontic Treatment, Menstrual Cycle and Menopause, sponsored by Nigde Omer Halisdemir University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Nigde Omer Halisdemir University · Observational

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.
Updated Sep 30, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
130
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,722 studies in Pain with a site in Turkey — 321 open to participants now, 374 under way, none of them phase 3. Pain · Turkey.

Planned enrollment
53rd of 223
130 · median 84
Started
2026
with 185 others
Observational
223 of 1,722
58 open now
Primary completion
2027-03
later than 329 of 373 live
Registered
1,681st of 1,722
by date

Among the 1,722 studies in Pain with a site in Turkey, this one is the 53rd largest by planned enrollment of the 223 observational ones that give a count, is one of 186 that started in 2026, is one of 223 observational ones, reaches primary completion later than 329 of the 373 other live ones, and was the 1,681st registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

321 of the 1,722 studies in Pain with a site in Turkey are open now. Recruiting first, the newest first:

316 more — sign in →

All 321 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,722 studies in Pain with a site in Turkey, or all of them as a file.
02

Study summary

The goal of this observational study is to investigate whether menstrual cycle phases and menopausal status are associated with pain perception in patients undergoing endodontic treatment. The main questions it aims to answer are:

Does pain experienced during endodontic treatment differ according to the phase of the menstrual cycle? Is pain perception during endodontic treatment different between premenopausal and postmenopausal women? Are menstrual cycle phases and menopausal status associated with pain experienced after endodontic treatment?

Participants undergoing endodontic treatment as part of their routine dental care will provide information about their menstrual cycle or menopausal status. Pain will be assessed at different stages of treatment and during the follow-up period after treatment. No treatment will be assigned based on menstrual cycle phase or menopausal status.

03

Conditions studied

  • Pain Perception in Endodontic Treatment
  • Menstrual Cycle
  • Menopause

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Women aged 18 years or older who present to the Department of Endodontics, Faculty of Dentistry, Nigde Omer Halisdemir University and require root canal treatment. Eligible participants who voluntarily agree to participate will be included and classified according to menstrual cycle phase (follicular or luteal phase) or postmenopausal status.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Willing to participate in the study
  • Aged 18 years or older
  • Having at least one tooth requiring root canal treatment

Exclusion criteria

Exclusion Criteria:

  • Aged under 18 years
  • No tooth requiring root canal treatment
  • Male sex
  • Diagnosis of endometriosis or polycystic ovary syndrome (PCOS)
  • Use of oral
  • Receiving hormone therapy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
130 participants (estimated)
Patient registry
No

Groups and cohorts

  • Follicular Phase Group

    Women undergoing routine endodontic treatment who are in the follicular phase of their menstrual cycle.

  • Luteal Phase Group

    Women undergoing routine endodontic treatment who are in the luteal phase of their menstrual cycle.

  • Postmenopausal Group

    Postmenopausal women undergoing routine endodontic treatment.

06

What researchers measure

Primary outcomes

  1. Pain Intensity Assessed Using the Visual Analog Scale

    Pain intensity will be assessed using the 100-mm Visual Analog Scale (VAS), ranging from 0 to 100 mm, with higher scores indicating greater pain intensity. Pain scores will be compared among participants in the follicular phase, luteal phase, and postmenopausal groups.

    Time frame: -Before treatment(baseline) -Immediately after local anesthetic injection -Immediately after completion of endodontic treatment -Postoperative Day 1 -Postoperative Day 2

Secondary outcomes

  1. Dental Anxiety Assessed Using the Modified Dental Anxiety Scale

    Dental anxiety will be assessed using the 5-item Modified Dental Anxiety Scale (MDAS), with total scores ranging from 5 to 25. Higher scores indicate greater dental anxiety. Scores will be evaluated among participants in the follicular phase, luteal phase, and postmenopausal groups.

    Time frame: Before endodontic treatment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Mar 2027, 12 months after the start.

Of 505 non-industry observational studies under Pain, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 42. This study's planned 12 months is below that.

Counting every sponsor, half of 520 studies reached it within 18 months; a quarter within 8 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2026
First posted
Sep 30, 2026
StartActual
Mar 10, 2026
Primary completionEst.
Mar 2027
CompletionEst.
Mar 2027
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07850167
Lead sponsor
Nigde Omer Halisdemir University
Responsible party
Zübeyde Gökçe ÜRÜN (Assistant Professor, Nigde Omer Halisdemir University) — Principal investigator
First posted
Sep 30, 2026
Start date
Mar 10, 2026
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Sep 30, 2026

Study contacts

Zübeyde Gökçe Ürün, Assistant Professor
Contact
gurun@ohu.edu.tr
+905378880030

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion